State Street’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.3M Buy
3,027,173
+337,630
+13% +$3.93M ﹤0.01% 1866
2025
Q1
$20M Sell
2,689,543
-40,358
-1% -$300K ﹤0.01% 2145
2024
Q4
$16.4M Buy
2,729,901
+178,116
+7% +$1.07M ﹤0.01% 2330
2024
Q3
$13.1M Buy
2,551,785
+48,885
+2% +$250K ﹤0.01% 2454
2024
Q2
$9.06M Sell
2,502,900
-177,646
-7% -$643K ﹤0.01% 2619
2024
Q1
$8.6M Buy
2,680,546
+88,893
+3% +$285K ﹤0.01% 2670
2023
Q4
$12.7M Buy
2,591,653
+56,612
+2% +$277K ﹤0.01% 2457
2023
Q3
$13.8M Sell
2,535,041
-9,587
-0.4% -$52.2K ﹤0.01% 2405
2023
Q2
$17.1M Sell
2,544,628
-23,414
-0.9% -$157K ﹤0.01% 2340
2023
Q1
$22.7M Buy
2,568,042
+66,589
+3% +$588K ﹤0.01% 2140
2022
Q4
$19.1M Buy
2,501,453
+25,018
+1% +$191K ﹤0.01% 2272
2022
Q3
$17.6M Buy
2,476,435
+137,051
+6% +$976K ﹤0.01% 2313
2022
Q2
$18.9M Buy
2,339,384
+464,913
+25% +$3.76M ﹤0.01% 2288
2022
Q1
$26M Buy
1,874,471
+243,581
+15% +$3.38M ﹤0.01% 2208
2021
Q4
$45.8M Buy
1,630,890
+105,132
+7% +$2.95M ﹤0.01% 1867
2021
Q3
$51.9M Buy
1,525,758
+98,837
+7% +$3.36M ﹤0.01% 1778
2021
Q2
$58.3M Buy
1,426,921
+473,378
+50% +$19.3M ﹤0.01% 1731
2021
Q1
$38.4M Sell
953,543
-1,791
-0.2% -$72.1K ﹤0.01% 1935
2020
Q4
$56.5M Buy
955,334
+34,767
+4% +$2.06M ﹤0.01% 1568
2020
Q3
$44.8M Buy
920,567
+107,210
+13% +$5.21M ﹤0.01% 1539
2020
Q2
$39.4M Buy
813,357
+99,461
+14% +$4.81M ﹤0.01% 1596
2020
Q1
$19.8M Buy
713,896
+454,043
+175% +$12.6M ﹤0.01% 1843
2019
Q4
$7.78M Buy
259,853
+112,222
+76% +$3.36M ﹤0.01% 2645
2019
Q3
$4.56M Buy
+147,631
New +$4.56M ﹤0.01% 2829